{
 "@context" : "http://schema.org",
  "id" : "http://bio2rdf.org/drugbank:DB00229",
  "type" : "Drug",
  "clinicalPharmacology" : "Cefotiam is a third generation beta-lactam cephalosporin antibiotic. It has broad spectrum activity against Gram positive and Gram negative bacteria. It does not have activity against <i>Pseudomonas aeruginosa</i>. Cefotiam works by inhibiting bacterial cell wall biosynthesis.",
  "description" : "One of the cephalosporins that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms. [PubChem]",
  "drugClass" : [ "Anti-Bacterial Agents", "Cephalosporins" ],
  "schema:identifier" : "drugbank:DB00229",
  "interactingDrug" : [ "DDI between Cefotiam and Probenecid - Probenecid may increase the serum concentration of Cephalosporins.", "DDI between Cefotiam and Acenocoumarol - May enhance the anticoagulant effect of Vitamin K Antagonists." ],
  "legalStatus" : "Approved",
  "manufacturer" : {
    "id" : "http://bio2rdf.org/drugbank_resource:ad7e1515f34f0204304e0b647d02f927",
    "type" : "Organization",
    "name" : "Takeda chemical industries ltd"
  },
  "mechanismOfAction" : "The bactericidal activity of cefotiam results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).",
  "name" : "Cefotiam",
  "nonProprietaryName" : [ "(6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid", "Cefotiamum", "CEFOTIAM", "CTM" ],
  "proprietaryName" : "Ceradon",
  "sameAs" : "http://www.drugbank.ca/drugs/DB00229",
  "schema:url" : "http://bio2rdf.org/drugbank:DB00229"
}